A urine test for bladder cancer has just been through its largest real-world evaluation in the NHS, and the results are the strongest evidence yet that a lab sample can help decide who needs a camera examination. Among 964 people referred urgently because of blood in their urine, the test picked up 71 of the 77 bladder cancers eventually diagnosed, including every muscle-invasive tumour in the study. The findings were published in European Urology Oncology on 2 September 2026. They matter because most people sent down that urgent pathway turn out not to have cancer: here, only 8 in 100 did. In this article you will learn what the test measures, how it sits alongside the checks you already know, what a negative result means, and what still has to be confirmed.
What the study actually tested
The urine test for bladder cancer assessed here, called GALEAS Bladder, was developed with the University of Birmingham’s Bladder Cancer Research Centre and the diagnostics company Nonacus. It reads DNA that bladder cells shed into urine, looking for more than 450 mutations across 23 genes linked to bladder cancer. A person passes urine into a container, and a laboratory returns a result in five to ten working days.
Between October 2024 and June 2025, seven NHS urology departments enrolled people referred urgently for haematuria, the medical word for blood in the urine. Everyone had both the urine test and the standard camera examination, so the two could be compared directly. The study was funded by the company that makes the test, which is usual at this stage of development but worth knowing when you read the figures.
Why blood in the urine sends so many people to hospital
Blood in the urine is the sign most often associated with bladder cancer, and guidance is deliberately cautious: it should always be checked. The difficulty is that the same sign is produced by far more common conditions, including urinary infections, kidney stones, an enlarged prostate and hard exercise. Our explainer covers blood in the urine and its usual causes.
The result is a crowded urgent pathway. In this study, 92 of every 100 people referred did not have bladder cancer, yet nearly all of them went through the same invasive assessment. The researchers modelled what would happen if the urine result were used to decide who is seen first: at the most cautious threshold they tested, roughly 730 urgent camera examinations per 1,000 referrals could have been deferred without losing overall clinical benefit. A separate overview describes bladder cancer symptoms and warning signs.
What the numbers mean in plain terms
Two figures do most of the work here, and both have plain-English meanings.
- Sensitivity, 92 percent: out of 100 people who did have bladder cancer, about 92 were flagged by the urine test.
- Negative predictive value, above 99 percent: when the test came back negative, the chance of not having bladder cancer was 99.3 percent.
Two details stand out. This urine test for bladder cancer found all 17 muscle-invasive cancers, the deeper and more serious tumours, and 35 of the 36 high-grade ones. And among the roughly 3 in 10 participants whose blood was visible only under a microscope, every cancer was picked up. That subgroup is precisely where a urine result helps most, because there is nothing to see with the naked eye. A companion article decodes a full urinalysis report.
How the urine test for bladder cancer compares with familiar checks
| Test | What it examines | What it is good at | Main limitation |
|---|---|---|---|
| Urine dipstick | Red blood cells and other markers, in seconds | Detecting blood you cannot see | Says nothing about the cause |
| Urine cytology | The appearance of cells under a microscope | Spotting high-grade cancer cells | Misses many slow-growing tumours |
| Urine DNA test | Tumour mutations in shed DNA | Making a negative result reassuring | An adjunct, not a diagnosis |
| Cystoscopy | The bladder wall itself, through a camera | Seeing and sampling a tumour directly | Invasive and resource-heavy |
Cytology remains useful, but it has long been known to miss slow-growing tumours, and that gap is exactly what molecular urine tests are trying to close. Our guide explains urine cytology results and what follows them.
Latest scientific advances in urine tests for bladder cancer
The Birmingham results are not an isolated finding. Three other recent studies help place what a urine test for bladder cancer can and cannot do today.
A protein panel tested in everyday clinics
In 2025, researchers reported on a urine test that measures ten proteins at once, in 1,000 people attending haematuria clinics in the United States, Europe and Japan. It correctly identified about 85 in every 100 cancers, and a negative result was reliable enough that the authors estimated two thirds of patients could have avoided a camera examination. What this means for you: several different technologies are converging on the same goal, which strengthens the overall case rather than resting it on one product.
A methylation test aimed at the tumours cytology misses
A 2026 study of 892 people in Korea and the United States assessed a test that reads chemical marks, called methylation, on one gene in urine DNA. It detected roughly 88 in every 100 cancers and almost all the high-grade ones, and it improved detection of the slow-growing tumours that cytology tends to miss. What this means for you: the weakest point of the older urine test is the one newer tests are targeting first.
The caution that comes with all of them
A 2024 systematic review, a study that gathers and appraises all the evidence on one question, examined 28 studies of five commercially available urine tests used during a haematuria work-up. Performance varied widely between them, and the authors concluded that none had yet shown enough evidence to replace the camera examination as the reference standard. What this means for you: these tests are being added to the pathway to help decide who is seen first, not to remove a step from it. Our news desk also reviewed multi-cancer early detection tests.
What the urine test for bladder cancer does not change
A negative urine test is reassurance, not a discharge. Blood you can see in your urine still needs assessment, even if it happened once and stopped, and even if a test comes back clear. Nothing in these studies changes the advice to see a doctor promptly for visible blood, unexplained weight loss, or urinary symptoms that persist. And no urine test confirms a cancer on its own: that still requires tissue examined under a microscope.
It is also worth being clear about what these tests are not. None is a population screening test. Health authorities do not recommend routine bladder cancer screening for people at average risk, partly because false alarms are common with blood-in-urine testing. Everyone in these studies already had a reason to be investigated. Another page explains leucocytes in a urine sample, and one guide reviews nitrites in urine, both of which point instead toward infection. A separate article describes urinary tract infection symptoms, and one explainer covers urine colour and what it signals.
Frequently asked questions
Can a urine test for bladder cancer replace a cystoscopy?
Not today. In the NHS study the urine test was used to decide who should be seen first and who could reasonably wait, not to remove the camera examination from the pathway. A 2024 review of five commercial urine tests reached the same conclusion: none has yet shown enough evidence to take the place of cystoscopy. If a urine result is positive, a camera examination and tissue sampling are still needed to confirm what is there.
Is this test available to me now?
Availability depends on where you live and how your health service is organised. The test studied is already used in some NHS pathways in England and Wales, with more sites adopting it. In other countries, similar molecular urine tests exist but are not uniformly funded or offered. Your doctor or urology team is the right person to ask what is available locally.
What does a negative urine DNA test actually tell me?
In this study, a negative result meant a 99.3 per cent probability of not having bladder cancer at that moment. That is high, but it is not certainty, and it is a snapshot rather than a guarantee for the future. If your symptoms continue or change, say so, whatever the earlier result showed.
I have blood in my urine but I feel fine. Should I still get checked?
Yes. Blood in the urine is often painless, and it is frequently intermittent, which is why people wait. Most causes turn out to be benign, but the assessment exists because the minority of serious causes are much easier to treat when they are found early.
Does microscopic blood in urine matter as much as visible blood?
Visible blood carries a higher risk overall, which is why it is investigated urgently. But microscopic blood is not nothing. In the NHS study, every cancer among participants with non-visible blood was detected by the urine test, and those cancers were real. The level of investigation is usually adjusted to your age, smoking history and other risk factors.
Do I need to prepare for a urine DNA test?
The sample is passed in the ordinary way, into a container provided by the laboratory. Unlike urine cytology, which asks you to avoid the very first urine of the morning because the cells degrade overnight, molecular tests generally have simpler instructions. Follow the sheet that comes with your kit, and tell the laboratory if you are menstruating or have a urinary infection, since both can affect results.
Glossary
| Term | Definition |
|---|---|
| Haematuria | Blood in the urine. Visible haematuria can be seen with the naked eye; non-visible haematuria is found only on a dipstick or under a microscope. |
| Cystoscopy | An examination in which a thin camera is passed through the urethra to look at the inside of the bladder. |
| Sensitivity | How well a test finds the people who do have the condition. A sensitivity of 92 percent means about 92 of every 100 cancers were detected. |
| Specificity | How well a test clears the people who do not have the condition, which is what keeps false alarms down. |
| Negative predictive value | The probability that someone with a negative result truly does not have the condition. |
| Muscle-invasive bladder cancer | A tumour that has grown into the muscle wall of the bladder, which usually calls for more intensive treatment. |
| Urine cytology | A laboratory test in which cells in a urine sample are examined under a microscope for abnormal or cancerous appearance. |
| DNA methylation | Chemical marks attached to DNA that switch genes on or off. Their pattern often changes in cancer cells, which is what some urine tests measure. |
| Systematic review | A study that gathers, appraises and summarises all the research published on one question, rather than reporting a single experiment. |
Sources
- National Cancer Institute. Bladder Cancer Screening (PDQ) — Patient Version, 2023. cancer.gov
- MedlinePlus, National Library of Medicine. Urine — bloody, reviewed 2025. medlineplus.gov
- Cleveland Clinic. Urine Cytology: purpose, procedure and results, 2022. my.clevelandclinic.org
- University of Birmingham and Nonacus. Real-World Multicentre Evaluation of GALEAS Bladder for Detecting Bladder Cancer in UK NHS Haematuria Clinics — European Urology Oncology, 2026. doi.org/10.1016/j.euo.2026.08.005
- Pagano I, et al. Performance of the Oncuria-Detect bladder cancer test for evaluating patients presenting with haematuria: results from a real-world clinical setting — Journal of Translational Medicine, 2025. consensus.app
- Oh TJ, et al. EarlyTect BCD Plus: a urine-based dual site PENK methylation test for risk-based cystoscopy triage in haematuria — BJUI Compass, 2026. consensus.app
- Heard JR, et al. Noninvasive Tests for Bladder Cancer Detection and Surveillance: A Systematic Review of Commercially Available Assays — Bladder Cancer, 2024. consensus.app
Further reading
- Protein in urine: causes, symptoms and risks
- Crystals in urine: what your result means
- Urine creatinine: a yardstick, not a result
- Normal urine pH: range, causes and meaning
- Colon cancer blood test: what FDA approval means
Understand your lab results with AI DiagMe
A urine report is easier to act on when you know which line is doing the work. Red blood cells, leukocytes, nitrites and protein each point in a different direction, and the difference between a urinary infection and a finding that deserves a urology opinion often sits in that combination. AI DiagMe reads your blood, urine and stool results and explains them in plain language, so you arrive at your appointment with the right questions. It helps you understand your results; it does not make a diagnosis and does not replace your doctor.
Get your results interpreted in minutes
